Premium
Opioid substitution to reduce adverse effects in cancer pain management
Author(s) -
Ashby Michael A,
Martin Peter,
Jackson Kate A
Publication year - 1999
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1999.tb126885.x
Subject(s) - medicine , palliative care , adverse effect , opioid , nausea , opiate substitution treatment , emergency medicine , intensive care medicine , anesthesia , buprenorphine , nursing , receptor
Objective To assess the effect of opioid substitution (substituting one member of the opioid class for another) on the incidence and severity of adverse effects in palliative‐ care patients who experience unacceptable, refractory adverse effects when taking an opioid drug. Design Prospective audit of clinical records. Setting Palliative Care Program, Monash Medical Centre, Melbourne, Victoria (comprising an acute 10‐bed palliative care unit and a palliative care consultative service). Patients All palliative care inpatients and patients referred to the consultative service who underwent opioid substitution between February 1996 and June 1997. Outcome measures Adverse effects and pain control profiles before and after opioid substitution. Results 55 opioid substitutions were undertaken in 49 patients. 49 substitutions were for adverse effects. The substitution produced partial or complete relief from confusion in 18 of 25 cases, from nausea and vomiting in 13 of 19, and from drowsiness in 8 of 15. Substitution also abolished myoclonus associated with renal failure in one patient. Conclusion We found that the incidence and severity of adverse effects differed between opioids in the same patient. A trial of opioid substitution (usually in consultation with a specialist pain or palliative care unit and with auditing of outcomes) should be considered for patients with intolerable, refractory adverse effects of opioids.